Kymera Therapeutics, Inc.
KYMR
$22.20
-$1.49-6.29%
| Weiss Ratings | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.53 | |||
| Price History | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -26.95% | |||
| 30-Day Total Return | -39.69% | |||
| 60-Day Total Return | -45.75% | |||
| 90-Day Total Return | -48.98% | |||
| Year to Date Total Return | -45.71% | |||
| 1-Year Total Return | -38.74% | |||
| 2-Year Total Return | -25.55% | |||
| 3-Year Total Return | -47.83% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -55.53% | |||
| 52-Week Low % Change | 0.21% | |||
| Price | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $53.27 | |||
| 52-Week Low Price | $23.64 | |||
| 52-Week Low Price (Date) | Apr 03, 2025 | |||
| 52-Week High Price (Date) | Sep 26, 2024 | |||
| Valuation | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.54B | |||
| Enterprise Value | 775.38M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.97 | |||
| Earnings Per Share Growth | 17.79% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 40.26 | |||
| Price/Book (Q) | 1.84 | |||
| Enterprise Value/Revenue (TTM) | 16.47 | |||
| Price | $22.20 | |||
| Enterprise Value/EBITDA (TTM) | -3.09 | |||
| Enterprise Value/EBIT | -3.02 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 79.99M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 857 285 5300 | |||
| Address | 200 Arsenal Yards Boulevard Watertown, MA 02472 | |||
| Website | www.kymeratx.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -545.35% | |||
| Profit Margin | -475.56% | |||
| Management Effectiveness | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -20.65% | |||
| Return on Equity | -- | |||
| Income Statement | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 47.07M | |||
| Total Revenue (TTM) | 47.07M | |||
| Revenue Per Share | $0.59 | |||
| Gross Profit (TTM) | -193.18M | |||
| EBITDA (TTM) | -250.74M | |||
| EBIT (TTM) | -256.71M | |||
| Net Income (TTM) | -223.86M | |||
| Net Income Avl. to Common (TTM) | -223.86M | |||
| Total Revenue Growth (Q YOY) | -84.56% | |||
| Earnings Growth (Q YOY) | -392.43% | |||
| EPS Diluted (TTM) | -2.97 | |||
| EPS Diluted Growth (Q YOY) | -260.29% | |||
| Balance Sheet | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 488.74M | |||
| Cash Per Share (Q) | $6.11 | |||
| Total Current Assets (Q) | 510.27M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 835.62M | |||
| Current Ratio (Q) | 7.530 | |||
| Book Value Per Share (Q) | $12.88 | |||
| Total Assets (Q) | 978.04M | |||
| Total Current Liabilities (Q) | 67.77M | |||
| Total Debt (Q) | 87.76M | |||
| Total Liabilities (Q) | 142.42M | |||
| Total Common Equity (Q) | 835.62M | |||
| Cash Flow | KYMR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -404.08M | |||
| Cash from Financing (TTM) | 608.85M | |||
| Net Change in Cash (TTM) | 10.27M | |||
| Levered Free Cash Flow (TTM) | -126.81M | |||
| Cash from Operations (TTM) | -194.50M | |||
